drugset
drugset / Trial / NCT00266357

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

NCT00266357 ↗

Phase 2 Terminated 50 enrolled H. Lundbeck A/S
RandomizedCrossoverDouble-blindTreatment

Summary

A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.

Timeline

Start
2005-11
Primary completion
2007-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject gaboxadol Small molecule — —

Indications

insomnia